Login
$VYGR
$1.78 +$0.03 (1.71%) Live

Company Executives

$VYGR Management Team

Mr. Michael Higgins

Independent Chairman of the Board

Age 62
Compensation $227.5K USD
Sex Male

Ms. Robin Swartz

Chief Operating Officer

Chief Business Officer

Age 54
Compensation $1.381M USD
Sex Female

Dr. Todd Carter

Chief Scientific Officer

Age 55
Compensation -
Sex Male

Dr. Alfred Sandrock

President

Chief Executive Officer

Director

Age 67
Compensation $3.377M USD
Sex Male

Dr. Nathan Jorgensen

Chief Financial Officer

Principal Financial Officer

Principal Accounting Officer

Age 48
Compensation $1.870M USD
Sex Male

Ms. Jacquelyn Fahey Sandell

Chief Legal Officer

Age 56
Compensation $1.677M USD
Sex Female

Dr. Toby Ferguson

Chief Medical Officer

Age 55
Compensation $2.969M USD
Sex Male
Directors
10
serving now
Independent
0 of 2
stated in the proxy; 8 not stated
Average tenure
6.6 years
from year joined
CEO also chairs the board
No
Michael Higgins
Director Age On board Independent Committees Other public boards 2025 pay Source
James A. Geraghty
71 2014
12 years
Not stated None stated Fulcrum Therapeutics, CanBridge Pharma $107,260
Steven Hyman, M.D.
73 2015
11 years
Not stated None stated Cyclerion Therapeutics, Inc. $107,760
Alfred Sandrock, M.D., Ph.D.
68 2022
4 years
Not independent None stated None stated Paid as CEO
Michael Higgins
63 2015
11 years
Not stated None stated Pulmatrix, Inc. $146,260
Jude Onyia, Ph.D.
62 2023
3 years
Not independent
Science and Technology Committee
None stated $98,760
Nancy Vitale
55 2020
6 years
Not stated None stated None stated $108,760
Grace E. Colón, Ph.D.
59 2023
3 years
Not stated
Audit Committee
None stated $107,760
Catherine J. Mackey, Ph.D.
70 2022
4 years
Not stated
Science and Technology Committee
IDEAYA Biosciences, Inc. $106,760
Glenn Pierce, M.D., Ph.D.
70 2017
9 years
Not stated None stated None stated $104,760
George Scangos, Ph.D.
78 2023
3 years
Not stated None stated Agilent Technologies, Inc. $103,760

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

9 disclosed in the proxy filed Apr 28, 2026
Entities affiliated with EcoR1 Capital, LLC
Amount not stated

Purchase of common stock and pre-funded warrants in the 2024 Public Offering

With Company Open in proxy
Entities affiliated with Armistice Capital LLC
Amount not stated

Purchase of common stock in the 2024 Public Offering

With Company Open in proxy
Entities affiliated with BlackRock, Inc.
Amount not stated

Purchase of common stock in the 2024 Public Offering

With Company Open in proxy
EcoR1 Capital
Amount not stated
2025

Cashless exercise of all outstanding pre-funded warrants resulting in issuance of 3,332,544 net shares

With Company Open in proxy
Jacquelyn Fahey Sandell, J.D.
former Chief Legal Officer and Secretary
An aggregate of $487,508
2025

Separation agreement providing salary continuation for twelve months, prorated 2025 bonus, COBRA premium payments and outplacement services

With Company Open in proxy
Jacquelyn Fahey Sandell, J.D.
Executive officer
$29,750
2025

Consulting agreement with hourly consulting fees, expense reimbursement and modified equity award vesting

With Company Open in proxy
Peter Pfreundschuh
former Chief Financial Officer
An aggregate of $482,664
2024

Separation agreement providing salary continuation for twelve months, prorated 2024 bonus and COBRA premium payments

With Company Open in proxy
Peter Pfreundschuh
Executive officer
Amount not stated
2024

Consulting agreement with hourly consulting rate; no consulting fees paid for 2024 and modified equity award vesting

With Company Open in proxy
Neurocrine Biosciences, Inc.
beneficial owner of more than 5% of our voting securities
$34.1 million and $60.1 million of revenue
2024 and 2025

Collaboration and license agreements (2019 and 2023) for AAV gene therapy products, including cost reimbursements and collaboration revenue

With Company Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support